Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics announces $150 million private placement at $11.38 per share

Mixed Impact 4 of 5 financing Written later

MapLight agreed to sell 9,197,887 shares and pre-funded warrants for 3,983,168 shares to institutional investors at $11.38 per share, for gross proceeds of approximately $150.0 million before fees, with closing expected on August 14, 2026. The company also reported a second-quarter net loss of $60.2 million, up from $29.8 million a year earlier, and says the financing and existing cash of $351.3 million should fund its lead program through 2028, which means existing shareholders will be diluted.

Key points

  • Private placement of 9,197,887 common shares and pre-funded warrants for 3,983,168 shares at $11.38 per share; gross proceeds of approximately $150.0 million before fees
  • Expected closing on August 14, 2026; placement agents are Morgan Stanley, Jefferies, Leerink Partners and Stifel
  • Q2 2026 net loss of $60.2 million vs. $29.8 million in Q2 2025; R&D expenses rose to $53.4 million from $26.8 million
  • Cash, cash equivalents and investments of $351.3 million at June 30, 2026; company expects runway through 2028 including the private placement proceeds

The filing

CompanyMapLight Therapeutics, Inc. (MPLT)
Form8-K, current report
Filed with the SECAug 13, 2026, 4:51 PM ET
Accession number0001193125-26-349490

Items reported: 1.01 Material Definitive Agreement2.02 Results of Operations3.02 Unregistered Equity Sale7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.